Home | Business News | Browse by Publication | B | Business Wire

Multimedia Available: FDA Clears Vasomedical''s EECP External Counterpulsation Therapy for Treatment of Congestive Heart Failure.

Publication: Business Wire
Publication Date: 17-JUN-02
Format: Online
Delivery: Immediate Online Access

Article Excerpt
Health/Medical Writers

ADVISORY...for Monday (June 17)

NOTE TO EDITORS: Multimedia Assets Available With This Story

Include Logos, Photos, Text News Releases

--(BUSINESS WIRE)

Vasomedical Inc. (Nasdaq:VASO) announced on June 17, 2002, that its proprietary EECP(R) enhanced external counterpulsation system has been granted a 510(k) market clearance from the Food...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Business Wire
AMCC Purchases InTime's Suite of Floorplanners., June 17, 2002
WallStreet Research Has Initiated Coverage On OnCure Technologies Corp..., June 17, 2002
ALSTOM Creates New Business to Provide Integrated Energy Management So..., June 17, 2002
Action Performance to Acquire Gift, Ornament Designer/Distributor; In ..., June 17, 2002
McClenahan Bruer Communications Opens San Francisco Office and Names G..., June 17, 2002

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.